Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProKidney Corp. - Class A Ordinary Shares (NQ:PROK)

2.360 +0.010 (+0.43%)
Streaming Delayed Price Updated: 10:29 AM EDT, Aug 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProKidney Corp. - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
ProKidney Stock Shoots Up Over 8% After Hours After Staggering 515% Rally On Wednesday
ProKidney (NASDAQ: PROK) experienced a surge of 515% during Tuesday's trading session and gained additional 8.58% after-hours to $4.05 on positive Phase 2 trial results, with trading volume seeing a... 
Via Benzinga
Prokidney, Soundhound AI, Quantumscape, Intel, And Nvidia: Why These 5 Stocks Are On Investors' Radars Today
U.S. major indices ended mixed on Tuesday, as the Dow Jones Industrial Average slipped nearly 0.4% to 44,240.76 and the S&P 500 edged down 0.1% to 6,225.52. 
Via Benzinga
Topics Artificial Intelligence Stocks
Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz
Via The Motley Fool
Topics Stocks
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Most active stocks in Tuesday's session
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session. 
Via Chartmill
Gold Falls 1%; ProKidney Shares Spike Higher
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Gapping stocks in Tuesday's session
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down. 
Via Chartmill
US Stocks Mixed; Small Business Sentiment Falls In June
 
Via Benzinga
Why Is Penny Stock ProKidney Trading Higher On Tuesday?
ProKidney stock jumps after Phase 2 trial shows rilparencel significantly slowed kidney function decline in patients with chronic kidney disease and diabetes. 
Via Benzinga
Tuesday's pre-market session: top gainers and losers
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes
From ProKidney
Via GlobeNewswire
Which stocks are moving after the closing bell on Friday?
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Top movers in Thursday's after hours session
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware
From ProKidney
Via GlobeNewswire
This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
 
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
What's going on in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights
From ProKidney
Via GlobeNewswire
ProKidney Reports Full Year 2024 Financial Results and Business Highlights
From ProKidney
Via GlobeNewswire
Top 3 Health Care Stocks You'll Regret Missing This Quarter
 
Via Benzinga
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From ProKidney
Via GlobeNewswire
ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
From ProKidney
Via GlobeNewswire
ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting
From ProKidney
Via GlobeNewswire
ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference
From ProKidney
Via GlobeNewswire
ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024
From ProKidney
Via GlobeNewswire
ProKidney to Participate in the UBS Virtual Organ Restoration Day
From ProKidney
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.